Literature DB >> 27114276

Adaptation of the [3H]Hypoxanthine Uptake Assay for In Vitro-Cultured Plasmodium knowlesi Malaria Parasites.

Megan S J Arnold1, Jessica A Engel1, Ming Jang Chua1, Gillian M Fisher1, Tina S Skinner-Adams1, Katherine T Andrews2.   

Abstract

The zoonotic malaria parasite Plasmodium knowlesi has recently been established in continuous in vitro culture. Here, the Plasmodium falciparum [(3)H]hypoxanthine uptake assay was adapted for P. knowlesi and used to determine the sensitivity of this parasite to chloroquine, cycloguanil, and clindamycin. The data demonstrate that P. knowlesi is sensitive to all drugs, with 50% inhibitory concentrations (IC50s) consistent with those obtained with P. falciparum This assay provides a platform to use P. knowlesi in vitro for drug discovery.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27114276      PMCID: PMC4914632          DOI: 10.1128/AAC.02948-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

2.  In vitro activity of cycloguanil against African isolates of Plasmodium falciparum.

Authors:  L K Basco; O Ramiliarisoa; P Ringwald; J C Doury; J Le Bras
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

3.  Expansion of host cellular niche can drive adaptation of a zoonotic malaria parasite to humans.

Authors:  Caeul Lim; Elsa Hansen; Tiffany M DeSimone; Yovany Moreno; Klara Junker; Amy Bei; Carlo Brugnara; Caroline O Buckee; Manoj T Duraisingh
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

4.  Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.

Authors:  Martin Smilkstein; Nongluk Sriwilaijaroen; Jane Xu Kelly; Prapon Wilairat; Michael Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

5.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

6.  Adaptation of the genetically tractable malaria pathogen Plasmodium knowlesi to continuous culture in human erythrocytes.

Authors:  Robert W Moon; Joanna Hall; Farania Rangkuti; Yung Shwen Ho; Neil Almond; Graham H Mitchell; Arnab Pain; Anthony A Holder; Michael J Blackman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

7.  A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

Authors:  Selidji Todagbe Agnandji; Bertrand Lell; José Francisco Fernandes; Béatrice Peggy Abossolo; Barbara Gaelle Nfono Ondo Methogo; Anita Lumeka Kabwende; Ayola Akim Adegnika; Benjamin Mordmüller; Saadou Issifou; Peter Gottfried Kremsner; Jahit Sacarlal; Pedro Aide; Miguel Lanaspa; John J Aponte; Sonia Machevo; Sozinho Acacio; Helder Bulo; Betuel Sigauque; Eusébio Macete; Pedro Alonso; Salim Abdulla; Nahya Salim; Rose Minja; Maxmillian Mpina; Saumu Ahmed; Ali Mohammed Ali; Ali Takadir Mtoro; Ali Said Hamad; Paul Mutani; Marcel Tanner; Halidou Tinto; Umberto D'Alessandro; Hermann Sorgho; Innocent Valea; Biébo Bihoun; Issa Guiraud; Berenger Kaboré; Olivier Sombié; Robert Tinga Guiguemdé; Jean Bosco Ouédraogo; Mary J Hamel; Simon Kariuki; Martina Oneko; Chris Odero; Kephas Otieno; Norbert Awino; Meredith McMorrow; Vincent Muturi-Kioi; Kayla F Laserson; Laurence Slutsker; Walter Otieno; Lucas Otieno; Nekoye Otsyula; Stacey Gondi; Allan Otieno; Victorine Owira; Esther Oguk; George Odongo; Jon Ben Woods; Bernhards Ogutu; Patricia Njuguna; Roma Chilengi; Pauline Akoo; Christine Kerubo; Charity Maingi; Trudie Lang; Ally Olotu; Philip Bejon; Kevin Marsh; Gabriel Mwambingu; Seth Owusu-Agyei; Kwaku Poku Asante; Kingsley Osei-Kwakye; Owusu Boahen; David Dosoo; Isaac Asante; George Adjei; Evans Kwara; Daniel Chandramohan; Brian Greenwood; John Lusingu; Samwel Gesase; Anangisye Malabeja; Omari Abdul; Coline Mahende; Edwin Liheluka; Lincoln Malle; Martha Lemnge; Thor G Theander; Chris Drakeley; Daniel Ansong; Tsiri Agbenyega; Samuel Adjei; Harry Owusu Boateng; Theresa Rettig; John Bawa; Justice Sylverken; David Sambian; Anima Sarfo; Alex Agyekum; Francis Martinson; Irving Hoffman; Tisungane Mvalo; Portia Kamthunzi; Rutendo Nkomo; Tapiwa Tembo; Gerald Tegha; Mercy Tsidya; Jane Kilembe; Chimwemwe Chawinga; W Ripley Ballou; Joe Cohen; Yolanda Guerra; Erik Jongert; Didier Lapierre; Amanda Leach; Marc Lievens; Opokua Ofori-Anyinam; Aurélie Olivier; Johan Vekemans; Terrell Carter; David Kaslow; Didier Leboulleux; Christian Loucq; Afiya Radford; Barbara Savarese; David Schellenberg; Marla Sillman; Preeti Vansadia
Journal:  N Engl J Med       Date:  2012-11-09       Impact factor: 91.245

Review 8.  Designing the next generation of medicines for malaria control and eradication.

Authors:  Jeremy N Burrows; Rob Hooft van Huijsduijnen; Jörg J Möhrle; Claude Oeuvray; Timothy N C Wells
Journal:  Malar J       Date:  2013-06-06       Impact factor: 2.979

9.  P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action.

Authors:  Laura M Sanz; Benigno Crespo; Cristina De-Cózar; Xavier C Ding; Jose L Llergo; Jeremy N Burrows; Jose F García-Bustos; Francisco-Javier Gamo
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

10.  Susceptibility of human Plasmodium knowlesi infections to anti-malarials.

Authors:  Farrah A Fatih; Henry M Staines; Angela Siner; Mohammed Atique Ahmed; Lu Chan Woon; Erica M Pasini; Clemens Hm Kocken; Balbir Singh; Janet Cox-Singh; Sanjeev Krishna
Journal:  Malar J       Date:  2013-11-19       Impact factor: 2.979

View more
  6 in total

Review 1.  Clinical management of Plasmodium knowlesi malaria.

Authors:  Bridget E Barber; Matthew J Grigg; Daniel J Cooper; Donelly A van Schalkwyk; Timothy William; Giri S Rajahram; Nicholas M Anstey
Journal:  Adv Parasitol       Date:  2021-09-01       Impact factor: 3.125

2.  Investigating the antiplasmodial activity of primary sulfonamide compounds identified in open source malaria data.

Authors:  Gillian M Fisher; Silvia Bua; Sonia Del Prete; Megan S J Arnold; Clemente Capasso; Claudiu T Supuran; Katherine T Andrews; Sally-Ann Poulsen
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-01-13       Impact factor: 4.077

3.  Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.

Authors:  Ming Jang Chua; Megan S J Arnold; Weijun Xu; Julien Lancelot; Suzanne Lamotte; Gerald F Späth; Eric Prina; Raymond J Pierce; David P Fairlie; Tina S Skinner-Adams; Katherine T Andrews
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-12-23       Impact factor: 4.077

4.  Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum.

Authors:  Donelly A van Schalkwyk; Benjamin Blasco; Rocio Davina Nuñez; Jonathan W K Liew; Amirah Amir; Yee L Lau; Didier Leroy; Robert W Moon; Colin J Sutherland
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-02-22       Impact factor: 4.077

Review 5.  Current Treatments to Control African Trypanosomiasis and One Health Perspective.

Authors:  Alberto Venturelli; Lorenzo Tagliazucchi; Clara Lima; Federica Venuti; Giulia Malpezzi; George E Magoulas; Nuno Santarem; Theodora Calogeropoulou; Anabela Cordeiro-da-Silva; Maria Paola Costi
Journal:  Microorganisms       Date:  2022-06-27

6.  Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents.

Authors:  Donelly A van Schalkwyk; Robert W Moon; Benjamin Blasco; Colin J Sutherland
Journal:  J Antimicrob Chemother       Date:  2017-11-01       Impact factor: 5.790

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.